Investing
Figuring out how to invest your money to generate consistent returns can seem daunting, especially if you don’t have extensive financial knowledge. Our investing section provides novice investors with the key strategies and tips for how to invest money wisely. We deliver actionable advice to help you build wealth steadily over time.
Simply put, investing as a beginner can look confusing initially. But sticking to proven, time-tested investing principles can help you avoid costly mistakes and accumulate real returns. We believe successful investing doesn’t require taking excessive risk. By learning how to assess risk vs reward and allocating capital prudently, regular investors can steadily build wealth over the long run.
From setting investment goals and building a diversified portfolio to rebalancing and maximizing returns, we cover the essential investing basics. You’ll learn timeless wisdom from legendary investors like Warren Buffett and Peter Lynch that can guide your own investment decisions. We explain key terms and concepts clearly, so you can grasp investing fundamentals quickly.
While investing always involves some degree of risk, going in with the right knowledge helps tilt the odds in your favor. We believe the average individual has the ability to invest successfully on their own and grow significant wealth over time. By teaching you how to invest money wisely, we aim to empower our readers to take control of their financial futures.
Ready to start growing your money? Browse our investing for beginners articles covering stocks, mutual funds, ETFs, real estate, and alternative assets. Learn how to open a brokerage account, build a portfolio, and invest with a long-term mindset. Sign up for our free investing newsletter to get simple money tips delivered to your inbox daily.
Up 70% Since Beginning of This Year, Will Abercrombie’s Strong Run Continue Following Q1 Results?
Note: ANF’s FY’23 ended on February 3, 2024. Abercrombie & Fitch (NYSE: ANF), a specialty retailer selling casual clothing and footwear, is scheduled to ...
Bear of the Day: Cracker Barrel Old Country Store (CBRL)
Cracker Barrel Old Country Store CBRL owns and operates full-service dining locations with a restaurant and a retail store in the same unit. Analysts ...
3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List
In a shortened week of trading following the Memorial Day weekend, investors may want to take notice of several medical stocks that were added ...
Amazon (AMZN) Expands AWS Clientele with FWD Collaboration (revised)
Amazon AMZN is constantly gaining traction on the back of its robust cloud services portfolio. This is evident from the latest five-year agreement between ...
Should You Buy Stock Splits?
Many notable stock splits have occurred in recent years, with companies aiming to increase liquidity within shares and erase barriers to entry for potential ...
Earnings Estimates Moving Higher for Warby Parker (WRBY): Time to Buy?
Warby Parker Inc. (WRBY) appears an attractive pick given a noticeable improvement in the company’s earnings outlook. The stock has been a strong performer ...
Surging Earnings Estimates Signal Upside for Red Violet (RDVT) Stock
Red Violet, Inc. (RDVT) appears an attractive pick given a noticeable improvement in the company’s earnings outlook. The stock has been a strong performer ...
Builders FirstSource (BLDR) Stock Up 48% in a Year: Here’s Why
Builders FirstSource, Inc.’s BLDR shares gained 48% in the past year compared with the Zacks Building Products – Retail industry’s 9.7% increase. It is ...
Novartis (NVS) Presents Positive Data on Renal Drugs at ERA
Novartis NVS announced results from the six-month, double-blind trial period of the late-stage APPEAR-C3G study of Fabhalta. Fabhalta, an oral Factor B inhibitor of ...
Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
Apellis Pharmaceuticals APLS, in collaboration with Sobi, reported positive one-year results from the mid-stage study evaluating systemic pegcetacoplan to treat post-transplant recurrence of C3 glomerulopathy ...















